Arcadia Biosciences Income Statement - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.7 $0.01 (1.45%) RKDA stock closing price Mar 23, 2017 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Arcadia Biosciences stock price alone is not sufficient. In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. The income statement is generated for a specific period of time. The revenue decrease of $0.54M for 2016-Q4 impacts the RKDA stock. Investors typically check year over year or quarter over quarter revenue growth. The Arcadia Biosciences profit and loss statement for 2016-Q4 shows a profit of $-5.71M. Profits have reduced from $-4.18M QoQ. Apart from this an investor should also check Arcadia Biosciences assets and Arcadia Biosciences free cash flow. View details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Arcadia Biosciences Net Sales or Revenues
Cost Of Goods Sold (COGS)0.65M0.06M0.03M0.14M0.68M0.06M0.1M0.05M0.07M1.79M
Arcadia Biosciences Gross Profit
Research & Development Expense1.99M2.25M2.21M2.2M1.88M3.17M2.08M1.83M2.08M3.68M
Selling General & Admin Expense3.37M2.68M2.75M3.43M2.89M2.81M2.78M2.63M2.3M1.96M
Income Before Depreciation Depletion Amortization-5.47M-3.92M-4.28M-4.93M-4.08M-4.23M-3.54M-3.71M-1.64M-5.94M
Depreciation Depletion Amortization----------
Non Operating Income0.1M0.09M0.07M0.07M0.67M0.28M0.73M-1.39M0.02M-0.81M
Interest Expense0.33M0.33M0.32M0.32M0.66M0.76M0.77M0.46M0.36M0.26M
Arcadia Biosciences Pretax Income
Provision for Income Taxes-0.01M0.01M0.01M-0.2M-0.09M0.09M0.22M0.04M0.04M
Minority Interest----------
Investment Gains Losses---------0.01M-
Other Income----------
Income Before Extraordinaries & Disc Operations-5.71M-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS43.91M44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M
Average Shares used to compute Basic EPS43.91M44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M
Income Before Nonrecurring Items-5.71M-4.18M-4.55M-5.19M-3.63M-4.62M-3.68M-5.8M-1.99M-7.06M
Income from Nonrecurring Items-----0.23M-----
Arcadia Biosciences Earnings Per Share Basic Net
Arcadia Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.13-0.09-0.10-0.12-0.08-0.11-0.19-3.71-1.76-4.19
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Before investing one should read a report on Arcadia Biosciences stock analysis. It helps to look at the following income statement items:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that RKDA stock has a topline or revenue of $0.54M for 2016-Q4 as per this Arcadia Biosciences revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Arcadia Biosciences try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called statement of revenue and expense. The financials along with Arcadia Biosciences historical stock prices provides a lot of details about the firm. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield

Other Income Statements - Arcadia Biosciences Inc Industry Peers

The Andersons income statement, DuPont income statement, Dow Chemical income statement, Monsanto income statement